Elsevier Science Ltd.

SHERPA: Unknown

People

  1. Boelens
    Boelens
  2. O'Reilly
    O'Reilly
  3. Curran
    Curran
  4. Mcavoy
    Mcavoy
  5. Cancio
    Cancio
  6. Oved
    Oved
  7. Mauguen
    Mauguen
  8. Scaradavou
    Scaradavou
  9. Troullioud Lucas
    Troullioud Lucas
  10. Harris
    Harris

Groups

  1. Pediatrics, Department of (43)
  2. Stem Cell Transplantation and Cellular Therapy Service (43)
  3. Tow Center for Developmental Oncology (TCDO) (41)
  4. Department of Medicine (17)
  5. GSK Faculty (14)
  6. Sloan Kettering Institute Faculty (14)
  7. Immunology Program Faculty (12)
  8. Center for Molecular Imaging and Biotechnology (11)
  9. Center for Hematologic Malignancies (10)
  10. Biostatistics Service (9)
Search Within
  1. "Pediatrics, Department of"
Formats
  1. Meeting Abstract (23)
  2. Journal Article (10)
  3. Review (7)
  4. Guidelines (3)
Groups
  1. Pediatrics, Department of (43)
  2. Stem Cell Transplantation and Cellular Therapy Service (43)
  3. Tow Center for Developmental Oncology (TCDO) (41)
  4. Department of Medicine (17)
  5. GSK Faculty (14)
  6. Sloan Kettering Institute Faculty (14)

More Groups

People
  1. Jaap Jan Boelens (34)
  2. Richard O'Reilly (12)
  3. Susan Prockop (10)
  4. Devin Mcavoy (9)
  5. Elizabeth Klein (9)
  6. Kevin Curran (9)

More People

Years
  1. 2025 (7)
  2. 2024 (8)
  3. 2023 (5)
  4. 2022 (6)
  5. 2021 (3)
  6. 2020 (4)

More Years

Publications
  1. Cytotherapy (43)

Results (43)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Strategic infection prevention after genetically modified hematopoietic stem cell therapies: Recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering Committee
    Review

    John, T. D.; Maron, G.; Abraham, A.; Bertaina, A.; Bhoopalan, S. V.; Bidgoli, A.; Bonfim, C.; Coleman, Z.; DeZern, A.; Li, J.; more...
    Cytotherapy (2024)

    Fulltext@MSK | Save
  • High-dose individualized antithymocyte globulin with therapeutic drug monitoring in high-risk cord blood transplant
    Journal Article

    Admiraal, R.; Versluijs, A. B.; Huitema, A. D. R.; Ebskamp, L.; Lacna, A.; de Kanter, C. T. K.; Bierings, M. B.; Boelens, J. J.; Lindemans, C. A.; Nierkens, S.
    Cytotherapy (2024)

    Fulltext@MSK | Save
  • Engineering the best transplant outcome for high-risk acute myeloid leukemia: The donor, the graft and beyond
    Review

    Belbachir, S.; Abraham, A.; Sharma, A.; Prockop, S.; DeZern, A. E.; Bonfim, C.; Bidgoli, A.; Li, J.; Ruggeri, A.; Bertaina, A.; more...
    Cytotherapy (2024)

    Fulltext@MSK | Save
  • Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantation
    Journal Article

    Major-Monfried, H.; Hosszu, K.; McAvoy, D. P.; Vallone, A.; Shukla, N.; Gillio, A.; Spitzer, B.; Kung, A. L.; Cancio, M.; Curran, K.; more...
    Cytotherapy (2024)

    Fulltext@MSK | Save
  • Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell–depleted hematopoietic cell transplantation in pediatric and young adult patients
    Journal Article

    Lakkaraja, M.; Mauguen, A.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Harris, A. C.; Kernan, N. A.; Klein, E.; Kung, A. L.; Oved, J.; more...
    Cytotherapy (2024)

    Fulltext@MSK | Save
  • A comprehensive and collaborative workflow to establish customized endpoints and biomarkers for immunotherapy trials
    Meeting Abstract

    Vidal, E. H.; Mcavoy, D.; Vallone, A.; Thomsen, M.; Maslak, P.; Harris, A.; Oved, J.; Hosszu, K.; Boelens, J. J.
    Cytotherapy (2023)

    Fulltext@MSK | Save
  • Real world use of the pediatric disease risk index for allogeneic hematopoietic cell transplantation in patients with acute lymphoblastic leukemia: A multicenter study
    Meeting Abstract

    Lucas, A. T.; Nierkens, S.; de Koning, C.; Dandis, R.; Keerthi, D.; Naik, S.; Prockop, S.; Bhoopalan, S.; Boelens, J. J.; Lindemans, C.; more...
    Cytotherapy (2023)

    Fulltext@MSK | Save
  • Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; A tri-institutional analysis
    Journal Article

    Troullioud Lucas, A. G.; Lindemans, C. A.; Bhoopalan, S. V.; Dandis, R.; Prockop, S. E.; Naik, S.; Keerthi, D.; de Koning, C.; Sharma, A.; Nierkens, S.; more...
    Cytotherapy (2023)

    Fulltext@MSK | Save
  • International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant
    Review

    Garcia-Rosa, M.; Abraham, A.; Bertaina, A.; Bhoopalan, S. V.; Bonfim, C.; Cohen, S.; DeZern, A.; Louis, C.; Oved, J.; Pavel-Dinu, M.; more...
    Cytotherapy (2023)

    Fulltext@MSK | Save
  • Transplant for non-malignant disorders: An International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineering
    Guidelines

    Klein, O. R.; Bonfim, C.; Abraham, A.; Ruggeri, A.; Purtill, D.; Cohen, S.; Wynn, R.; Russell, A.; Sharma, A.; Ciccocioppo, R.; more...
    Cytotherapy (2023)

    Fulltext@MSK | Save

    • Elsevier Science Ltd. – authorized name for: